Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Ultrafast photodegradation of isoxazole and isothiazolinones by UV254 and UV254/H2O2 photolysis in a microcapillary reactor.

Russo D, Cochran KH, Westerman D, Li Puma G, Marotta R, Andreozzi R, Richardson SD.

Water Res. 2019 Oct 18;169:115203. doi: 10.1016/j.watres.2019.115203. [Epub ahead of print]

PMID:
31669902
2.

Descriptive Usability Study of CirrODS: Clinical Decision and Workflow Support Tool for Management of Patients With Cirrhosis.

Garvin JH, Ducom J, Matheny M, Miller A, Westerman D, Reale C, Slagle J, Kelly N, Beebe R, Koola J, Groessl EJ, Patterson ES, Weinger M, Perkins AM, Ho SB.

JMIR Med Inform. 2019 Jul 3;7(3):e13627. doi: 10.2196/13627.

3.

Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.

Blombery P, Birkinshaw RW, Nguyen T, Gong JN, Thompson ER, Xu Z, Westerman DA, Czabotar PE, Dickinson M, Huang DCS, Seymour JF, Roberts AW.

Br J Haematol. 2019 Sep;186(6):e188-e191. doi: 10.1111/bjh.16069. Epub 2019 Jun 24. No abstract available.

PMID:
31234236
4.

Using wastewater-based analysis to monitor the effects of legalized retail sales on cannabis consumption in Washington State, USA.

Burgard DA, Williams J, Westerman D, Rushing R, Carpenter R, LaRock A, Sadetsky J, Clarke J, Fryhle H, Pellman M, Banta-Green CJ.

Addiction. 2019 Sep;114(9):1582-1590. doi: 10.1111/add.14641. Epub 2019 Jun 18.

PMID:
31211480
5.

Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.

Goncalves I, Burbury K, Michael M, Iravani A, Ravi Kumar AS, Akhurst T, Tiong IS, Blombery P, Hofman MS, Westerman D, Hicks RJ, Kong G.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1902-1910. doi: 10.1007/s00259-019-04389-2. Epub 2019 Jun 11.

PMID:
31187162
6.

Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer.

Alexander M, Ball D, Solomon B, MacManus M, Manser R, Riedel B, Westerman D, Evans SM, Wolfe R, Burbury K.

Cancers (Basel). 2019 Jan 8;11(1). pii: E50. doi: 10.3390/cancers11010050.

7.

Parallel effects of retrieval ease on attributions about the past and the future.

Gregg J, Upadhyay SSN, Kuntzelman K, Sacchi E, Westerman DL.

Acta Psychol (Amst). 2019 Feb;193:96-104. doi: 10.1016/j.actpsy.2018.12.007. Epub 2018 Dec 30.

PMID:
30602131
8.

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.

Blombery P, Thompson E, Ryland GL, Joyce R, Byrne DJ, Khoo C, Lade S, Hertzberg M, Hapgood G, Marlton P, Deva A, Lindeman G, Fox S, Westerman D, Prince M.

Oncotarget. 2018 Nov 16;9(90):36126-36136. doi: 10.18632/oncotarget.26308. eCollection 2018 Nov 16.

9.

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.

Blombery P, Anderson MA, Gong JN, Thijssen R, Birkinshaw RW, Thompson ER, Teh CE, Nguyen T, Xu Z, Flensburg C, Lew TE, Majewski IJ, Gray DHD, Westerman DA, Tam CS, Seymour JF, Czabotar PE, Huang DCS, Roberts AW.

Cancer Discov. 2019 Mar;9(3):342-353. doi: 10.1158/2159-8290.CD-18-1119. Epub 2018 Dec 4.

PMID:
30514704
10.

Effects of HCO3- on Degradation of Toxic Contaminants of Emerging Concern by UV/NO3.

Huang Y, Kong M, Westerman D, Xu EG, Coffin S, Cochran KH, Liu Y, Richardson SD, Schlenk D, Dionysiou DD.

Environ Sci Technol. 2018 Nov 6;52(21):12697-12707. doi: 10.1021/acs.est.8b04383. Epub 2018 Oct 19.

PMID:
30284820
11.

"Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remission.

Rady K, Blombery P, Westerman DA, Wall M, Curtis M, Campbell LJ, Seymour JF.

Leuk Res. 2018 Oct;73:1-4. doi: 10.1016/j.leukres.2018.08.010. Epub 2018 Aug 16.

PMID:
30170269
12.

Picture (im)perfect: Illusions of recognition memory produced by photographs at test.

Wilson JC, Westerman DL.

Mem Cognit. 2018 Oct;46(7):1210-1221. doi: 10.3758/s13421-018-0832-6.

PMID:
29931619
13.

The Longest Obstructive Apnea You Have Ever Seen: A Patient With New-Onset Autonomic Dysfunction.

Aulakh PK, Westerman DE, Dedhia RC.

J Clin Sleep Med. 2018 May 15;14(5):893-895. doi: 10.5664/jcsm.7136.

14.

Transfer appropriate fluency: Encoding and retrieval interactions in fluency-based memory illusions.

Lanska M, Westerman D.

J Exp Psychol Learn Mem Cogn. 2018 Jul;44(7):1001-1012. doi: 10.1037/xlm0000496. Epub 2018 Apr 19.

PMID:
29672114
15.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.

Tam CS, Anderson MA, Pott C, Agarwal R, Handunnetti S, Hicks RJ, Burbury K, Turner G, Di Iulio J, Bressel M, Westerman D, Lade S, Dreyling M, Dawson SJ, Dawson MA, Seymour JF, Roberts AW.

N Engl J Med. 2018 Mar 29;378(13):1211-1223. doi: 10.1056/NEJMoa1715519.

16.

Changing role of bone marrow examination in the diagnosis of hematological malignancies.

Juneja S, Westerman D.

Leuk Lymphoma. 2018 Sep;59(9):2018-2020. doi: 10.1080/10428194.2018.1430798. Epub 2018 Feb 12. No abstract available.

PMID:
29431563
17.

Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory.

Blombery P, Jones K, Doig K, Ryland G, McBean M, Thompson E, Yannakou CK, Westerman D.

Arch Pathol Lab Med. 2018 May;142(5):606-612. doi: 10.5858/arpa.2017-0229-OA. Epub 2018 Feb 9.

PMID:
29425073
18.

ASXL1 c.1934dup;p.Gly646Trpfs*12-a true somatic alteration requiring a new approach.

Yannakou CK, Jones K, McBean M, Thompson ER, Ryland GL, Doig K, Markham J, Westerman D, Blombery P.

Blood Cancer J. 2017 Dec 15;7(12):656. doi: 10.1038/s41408-017-0025-8. No abstract available.

19.

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.

Rawstron AC, Kreuzer KA, Soosapilla A, Spacek M, Stehlikova O, Gambell P, McIver-Brown N, Villamor N, Psarra K, Arroz M, Milani R, de la Serna J, Cedena MT, Jaksic O, Nomdedeu J, Moreno C, Rigolin GM, Cuneo A, Johansen P, Johnsen HE, Rosenquist R, Niemann CU, Kern W, Westerman D, Trneny M, Mulligan S, Doubek M, Pospisilova S, Hillmen P, Oscier D, Hallek M, Ghia P, Montserrat E.

Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi: 10.1002/cyto.b.21595. Epub 2018 Jan 17.

20.

Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.

Blombery PA, Ryland GL, Markham J, Guinto J, Wall M, McBean M, Jones K, Thompson ER, Cameron DL, Papenfuss AT, Prince MH, Dickinson M, Westerman DA.

Br J Haematol. 2018 Oct;183(1):146-149. doi: 10.1111/bjh.14919. Epub 2017 Sep 7. No abstract available.

PMID:
28880377
21.

Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.

Yannakou CK, Jones K, Ryland GL, Thompson ER, Reid G, McBean M, Trainer A, Westerman D, Blombery P.

J Clin Pathol. 2018 Jan;71(1):84-87. doi: 10.1136/jclinpath-2017-204481. Epub 2017 Aug 11.

PMID:
28801348
22.

Revelation effects in remembering, forecasting, and perspective taking.

Westerman DL, Miller JK, Lloyd ME.

Mem Cognit. 2017 Aug;45(6):1002-1013. doi: 10.3758/s13421-017-0710-7.

PMID:
28474279
23.

Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.

Anderson MA, Tam C, Lew TE, Juneja S, Juneja M, Westerman D, Wall M, Lade S, Gorelik A, Huang DCS, Seymour JF, Roberts AW.

Blood. 2017 Jun 22;129(25):3362-3370. doi: 10.1182/blood-2017-01-763003. Epub 2017 May 4.

PMID:
28473407
24.

Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia.

Yeh P, Hunter T, Sinha D, Ftouni S, Wallach E, Jiang D, Chan YC, Wong SQ, Silva MJ, Vedururu R, Doig K, Lam E, Arnau GM, Semple T, Wall M, Zivanovic A, Agarwal R, Petrone P, Jones K, Westerman D, Blombery P, Seymour JF, Papenfuss AT, Dawson MA, Tam CS, Dawson SJ.

Nat Commun. 2017 Mar 17;8:14756. doi: 10.1038/ncomms14756.

25.

Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.

Agarwal R, Blombery P, McBean M, Jones K, Fellowes A, Doig K, Forsyth C, Westerman DA.

Ann Hematol. 2017 May;96(5):725-732. doi: 10.1007/s00277-017-2937-6. Epub 2017 Feb 4.

PMID:
28161773
26.

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.

Yeh P, Dickinson M, Ftouni S, Hunter T, Sinha D, Wong SQ, Agarwal R, Vedururu R, Doig K, Fong CY, Blombery P, Westerman D, Dawson MA, Dawson SJ.

Blood. 2017 Mar 23;129(12):1685-1690. doi: 10.1182/blood-2016-09-740308. Epub 2017 Jan 26.

PMID:
28126926
27.

T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.

Hawkins ED, Duarte D, Akinduro O, Khorshed RA, Passaro D, Nowicka M, Straszkowski L, Scott MK, Rothery S, Ruivo N, Foster K, Waibel M, Johnstone RW, Harrison SJ, Westerman DA, Quach H, Gribben J, Robinson MD, Purton LE, Bonnet D, Lo Celso C.

Nature. 2016 Oct 27;538(7626):518-522. doi: 10.1038/nature19801. Epub 2016 Oct 17.

28.

Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.

Chan KL, van der Weyden C, Khoo C, Lade S, Blombery P, Westerman D, Khot A, Melo B, Johnstone RW, Prince HM, Dickinson M.

Leuk Lymphoma. 2017 Apr;58(4):996-998. doi: 10.1080/10428194.2016.1222375. Epub 2016 Aug 25. No abstract available.

PMID:
27558082
29.

Risk of thromboembolism with lymphoma: myth or reality?

Burbury KL, Alexander M, Westerman DA.

Leuk Lymphoma. 2016 Dec;57(12):2736-2738. Epub 2016 Jul 5. No abstract available.

PMID:
27379822
30.

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Blombery P, Thompson ER, Jones K, Arnau GM, Lade S, Markham JF, Li J, Deva A, Johnstone RW, Khot A, Prince HM, Westerman D.

Haematologica. 2016 Sep;101(9):e387-90. doi: 10.3324/haematol.2016.146118. Epub 2016 May 19. No abstract available.

31.

OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer - interim results from a prospective cohort study.

Alexander M, Wolfe R, Ball D, Manser R, McManus M, Riedel B, Solomon B, Westerman D, Burbury K.

Thromb Res. 2016 Apr;140 Suppl 1:S170. doi: 10.1016/S0049-3848(16)30122-0. Epub 2016 Apr 8.

PMID:
27161677
32.

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.

Anderson MA, Deng J, Seymour JF, Tam C, Kim SY, Fein J, Yu L, Brown JR, Westerman D, Si EG, Majewski IJ, Segal D, Heitner Enschede SL, Huang DC, Davids MS, Letai A, Roberts AW.

Blood. 2016 Jun 23;127(25):3215-24. doi: 10.1182/blood-2016-01-688796. Epub 2016 Apr 11.

33.

Copper deficiency mimicking myelodysplastic syndrome.

Rady K, Westerman D, Blombery P, Turner P, Seymour J.

Leuk Lymphoma. 2016 May;57(5):1223-6. doi: 10.3109/10428194.2015.1086920. Epub 2015 Dec 23. No abstract available.

PMID:
26693885
34.

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O, Kreuzer KA, Liptrot S, O'Brien D, de Tute RM, Marinov I, Hauwel M, Spacek M, Dobber J, Kater AP, Gambell P, Soosapilla A, Lozanski G, Brachtl G, Lin K, Boysen J, Hanson C, Jorgensen JL, Stetler-Stevenson M, Yuan C, Broome HE, Rassenti L, Craig F, Delgado J, Moreno C, Bosch F, Egle A, Doubek M, Pospisilova S, Mulligan S, Westerman D, Sanders CM, Emerson R, Robins HS, Kirsch I, Shanafelt T, Pettitt A, Kipps TJ, Wierda WG, Cymbalista F, Hallek M, Hillmen P, Montserrat E, Ghia P.

Leukemia. 2016 Apr;30(4):929-36. doi: 10.1038/leu.2015.313. Epub 2015 Dec 7.

35.

Fast-track rapid warfarin reversal for elective surgery: extending the efficacy profile to high-risk patients with cancer.

Byrne TJ, Riedel B, Ismail HM, Heriot A, Dauer R, Westerman D, Seymour JF, Kenchington K, Burbury K.

Anaesth Intensive Care. 2015 Nov;43(6):712-8.

36.

The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia.

Lee D, Grigoriadis G, Westerman D.

Pathology. 2015 Dec;47(7):609-21. doi: 10.1097/PAT.0000000000000319. Review.

PMID:
26517623
37.

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.

Lew TE, Cheah CY, Carney DA, Prince HM, Wolf M, Bazargan A, Januszewicz EH, Filshie R, Westerman D, Seymour JF, Tam CS.

Leuk Lymphoma. 2016 May;57(5):1044-53. doi: 10.3109/10428194.2015.1096353. Epub 2015 Nov 20.

PMID:
26464106
38.

Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection.

Came N, Nguyen V, Westerman D, Harrison S.

Br J Haematol. 2016 Jun;173(6):947-9. doi: 10.1111/bjh.13655. Epub 2015 Oct 12. No abstract available.

PMID:
26456706
39.

Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.

Agarwal R, Lade S, Liew D, Rogers TM, Byrne D, Feleppa F, Juneja S, Westerman DA.

J Clin Pathol. 2016 Mar;69(3):266-70. doi: 10.1136/jclinpath-2015-203002. Epub 2015 Aug 25.

PMID:
26307073
40.

The denominator variable in the quantitation of MRD in acute myeloid leukemia.

Came N, Westerman D, Juneja S.

Am J Hematol. 2015 Nov;90(11):E213-5. doi: 10.1002/ajh.24142. Epub 2015 Oct 12. No abstract available.

41.

Prevention of thromboembolism in myeloma: expanding the tool-box of assays to predict the risk?

Burbury KL, Dickinson M, Westerman DA, Prince HM.

Leuk Lymphoma. 2015;56(12):3246-7. doi: 10.3109/10428194.2015.1055487. Epub 2015 Jul 7. No abstract available.

PMID:
26054250
42.

Ependymal cells in cerebrospinal fluid: a traumatic occurrence.

Yeh P, Westerman DA.

Blood. 2015 Mar 19;125(12):2005. No abstract available.

PMID:
25954783
43.

Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts.

Read M, Liu D, Duong CP, Cullinane C, Murray WK, Fennell CM, Shortt J, Westerman D, Burton P, Clemons NJ, Phillips WA.

Ann Surg Oncol. 2016 Jan;23(1):305-11. doi: 10.1245/s10434-015-4425-3. Epub 2015 Feb 18.

PMID:
25691278
44.

How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.

Wong E, Ling V, Westerman D, Morgan S, Juneja S.

J Clin Pathol. 2015 Apr;68(4):301-5. doi: 10.1136/jclinpath-2014-202740. Epub 2015 Jan 21. Review.

PMID:
25609576
45.

On the (elusive) role of oral motor-movements in fluency-based memory illusions.

Westerman DL, Klin CM, Lanska M.

J Exp Psychol Learn Mem Cogn. 2015 Jul;41(4):1003-13. doi: 10.1037/xlm0000094. Epub 2015 Jan 12.

PMID:
25581224
46.

The effect of processing fluency on impressions of familiarity and liking.

Westerman DL, Lanska M, Olds JM.

J Exp Psychol Learn Mem Cogn. 2015 Mar;41(2):426-38. doi: 10.1037/a0038356. Epub 2014 Dec 22.

PMID:
25528088
47.

Lack of durable disease control with chemotherapy for mycosis fungoides and S├ęzary syndrome: a comparative study of systemic therapy.

Hughes CF, Khot A, McCormack C, Lade S, Westerman DA, Twigger R, Buelens O, Newland K, Tam C, Dickinson M, Ryan G, Ritchie D, Wood C, Prince HM.

Blood. 2015 Jan 1;125(1):71-81. doi: 10.1182/blood-2014-07-588236. Epub 2014 Oct 21.

PMID:
25336628
48.

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.

Cheah CY, Herbert KE, O'Rourke K, Kennedy GA, George A, Fedele PL, Gilbertson M, Tan SY, Ritchie DS, Opat SS, Prince HM, Dickinson M, Burbury K, Wolf M, Januszewicz EH, Tam CS, Westerman DA, Carney DA, Harrison SJ, Seymour JF.

Br J Cancer. 2014 Sep 9;111(6):1072-9. doi: 10.1038/bjc.2014.405. Epub 2014 Jul 29.

49.

Not enough familiarity for fluency: definitional encoding increases familiarity but does not lead to fluency attribution in associative recognition.

Lloyd ME, Hartman A, Ngo CT, Ruser N, Westerman DL, Miller JK.

Mem Cognit. 2015 Jan;43(1):39-48. doi: 10.3758/s13421-014-0449-3.

PMID:
25035187
50.

Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.

Herbert KE, Demosthenous L, Wiesner G, Link E, Westerman DA, Came N, Ritchie DS, Harrison S, Seymour JF, Prince HM.

Bone Marrow Transplant. 2014 Aug;49(8):1056-62. doi: 10.1038/bmt.2014.112. Epub 2014 Jun 2.

PMID:
24887382

Supplemental Content

Loading ...
Support Center